Stay current with the latest press releases from within the industry.
Release issued 6th June 2003
Australian Patent approval No: 756007 dated 12.08.1999 has just been announced for Sulidin LPS (Topical Nimesulide Gel).
Embil will continue to obtain Patent approvals in key markets worldwide, in order to better position itself in the manufacturing and distribution of topical nimesulide formulations on a worldwide basis.
If you want to find out more about the company visit Embil Pharmaceutical Co. Ltd. profile.
(17th November 2004) Sulidin® 1% Nimesulide LPS® gel receives European and US Patents
(7th November 2004) New Clinical Study results on SULIDIN® 1% Nimesulide LPS gel presented at the 8'th World Congress on Clinical Pharamacology and Therapeutics, Brisbane, Australia, 1-6 August 2004.
(29th December 2003) Two papers on Neo-Penotran® Forte and Neo-Penotran® Forte-L have been accepted for presentation at the 4'th World Conference on Vaginitis, Costa Rica, 10-13 Jan 2004
(10th October 2002) Recent Patent Approvals for SULIDIN® LPS® (Topical Nimesulide Gel)
(9th October 2002) Two New Clinical study reports released for Kortos® HC Cream used in the treatment of benign anorectal diseases.